Avid Bioservices Inc (CDMO)

[biopharm]

...Piper Jaffray would withhold its research on the company unless it was permitted to underwrite its secondary stock offerings.
..

Will we ever know the real reason why Piper Jaffray dropped coverage of Peregrine Pharmaceuticals? Maybe not.... but after reading the above post in full one MUST question their motives, especially since Immunotherapy is going to help Billions upon Billions.

I think Piper Jaffray should be ashamed after seeing this video:

Thank You Piper Jaffray for not helping Peregrine Pharmaceuticals and on biopharms blacklist ...I think its amazing that some here know more than some biotech analysts.

Next, if Peregrine comes up with some additional financing sometime over the next 14 trading days, then maybe Piper Jaffray withholding coverage of PPHM can be scrutinized even more so....

Analyst Coverage
Firm Analyst

NOBLE Life Science Partners Rahul Jasuja, Ph.D.
FBR & Co. Thomas Yip
ROTH Capital Partners Joseph Pantginis, Ph.D.

http://ir.peregrineinc.com/analysts.cfm